Lokken Investment Group »

Catalyst Pharmaceutical Partners shares owned by Lokken Investment Group

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Lokken Investment Group from 13F filings

Historical chart of Lokken Investment Group investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Lokken Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Lokken Investment Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $316k 16k 19.70
2025-06-30 $393k 18k 21.70
2025-03-31 $347k 14k 24.25

More positions owned by Lokken Investment Group

Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Spdr Gold Tr Gold Shs (GLD)
Unified Ser Tr Ballast Smlmd Cp (MGMT)
Vanguard Index Fds Small Cp Etf (VB)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Apple (AAPL)
Rbb Fund Trust First Eagle Over (FEOE)
Pimco Etf Tr Multisector Bd (PYLD)
Vaneck Etf Trust Clo Etf (CLOI)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Natixis Etf Tr Gateway Quality (GQI)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)

View all positions for Lokken Investment Group

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Fundsmith
American Century Companies
Dimensional Fund Advisors
Geode Capital Management
Renaissance Technologies
Royce & Associates
Arrowstreet Capital, Limited Partnership
Millennium Management
Charles Schwab Investment Management
Invesco
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners